Connection

Juan Horcajada to Pseudomonas aeruginosa

Back to Details
This is a "connection" page, showing publications Juan Horcajada has written about Pseudomonas aeruginosa.
Juan Horcajada
Connection Strength
1.399
Pseudomonas aeruginosa
  1. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical. J Infect. 2019 09; 79(3):253-261.
    View in: PubMed
    Score: 0.540
  2. Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infect Dis. 2017 01 05; 17(1):11.
    View in: PubMed
    Score: 0.455
  3. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients? Molecules. 2019 Feb 01; 24(3).
    View in: PubMed
    Score: 0.131
  4. Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model. Antimicrob Agents Chemother. 2018 05; 62(5).
    View in: PubMed
    Score: 0.124
  5. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain. Antimicrob Agents Chemother. 2017 11; 61(11).
    View in: PubMed
    Score: 0.120
  6. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.